Practical Takeaways: Sessions will explore updated government agency initiatives, goals, and priorities; promoting diversity, health equity, and inclusion in advertising; and trends in enforcement and regulation.

Government Speakers: Representatives from various FDA Centers, and other governmental agencies will provide the latest information on policy, enforcement, and future initiatives.

Peer Interaction: The conference will prioritize learning, engagement, and networking with fellow legal, regulatory, and marketing experts.

Call For Proposals

FDLI invites you to submit a proposal for a session for the Advertising & Promotion for Medical Products Conference. Your submissions and input are integral to ensuring that the most timely and pertinent topics are covered at the conference. Topics should address issues relating to advertising and promotion as it impacts the FDA-regulated community of medical products. Topics can be related specifically to drugs, biologics, medical devices, veterinary products, or be relevant to all.

Proposal Submission Guidelines

  • Topics should be at an advanced level.
  • Topics that include a variety of perspectives and viewpoints, including government, industry, private attorneys, academics, and public interest are preferred.
  • FDLI is committed to supporting, promoting, and celebrating diversity and inclusion in the food and drug law community. To that end, proposals addressing systematic or historical impacts on health care disparity and racial equity in relation to all areas of the FDA-regulated community are strongly encouraged.
  • We prefer submissions to include a reasonably detailed and thoughtful title for and description of the proposed session.

Submissions FAQ

  • Q: Am I limited in the number of proposals I can submit?
    • A: Multiple submissions from the same person or organization are welcome – however, each proposal requires its own form.
  • Q: How will my submission be reviewed?
    • A: All submissions are blinded before being reviewed by the Conference Planning Committee. All submissions are treated as recommendations, and proposals may be modified or combined by FDLI to best suit the needs of the conference.
  • Q: Do all items in my proposal need to be in final form?
    • A: No – Your proposal does not need to be in final form. A proposal can and will likely be updated by the Committee to include the newest or most up-to-date information as relevant for the FDLI audience.
  • Should I reach out to speakers I suggest in advance of submitting my proposal?
    • A: Suggested speakers should not be invited in advance – sessions are often combined and we cannot guarantee that suggested speakers will be included.
  • Q: Can I email you my submission?
    • All submissions must be received through the submission portal.
  • Q: If my topic is selected do I get to speak? Do I have to speak if my topic is selected?
    • A: Speaking opportunities are generally reserved for FDLI members. If your topic is selected, you will be invited to speak if you are interested; however, speaking is not a requirement to submit a topic.
  • Q: How will I know if my submission is accepted?
    • A: You will be notified of the status of your submission approximately three months before the conference date.

Proposal Submission Timeline

  • March 20: Call for Proposals opens.
  • April 28: Call for Proposals closes.
  • June: Those who submitted proposals will be notified of their submission’s status in late June.

Register by July 28 and SAVE!


Industry & Firms

  • +$400 for non-members
  • +$100 after 7/28/2023
  • +$200 after 9/8/2023


  • +$100 for non-members
  • +$100 after 7/28/2023
  • +$200 after 9/8/2023

Nonprofit & Academic

  • +$100 for non-members
  • +$100 after 7/28/2023
  • +$200 after 9/8/2023


  • +$400 for non-members
  • full-time students only
  • transcripts required


Internet Explorer and Microsoft Edge are not supported by the checkout process.

Please use Chrome, Firefox, or Safari.  If you are unable to use these browsers, please contact us at 202-371-1420 or [email protected] and we will assist you.



Sponsorship opportunities are available. Please let us know if you would like more information.

Gold Sponsor

Gold Sponsor

Gold Sponsor

Gold Sponsor

Gold Sponsor

Gold Sponsor



Silver Sponsor


Silver Sponsor


Silver Sponsor


Silver Sponsor


Bronze Sponsor


Planning Committee


Erin Carducci, Novartis Pharmaceuticals Corporation
Mark Gardner, Gardner Law, PLLC

Committee Members 

Heather Banuelos, King & Spalding LLP
Dale Cooke, PhillyCooke Consulting
Avia Dunn, Skadden, Arps, Slate, Meagher & Flom LLP
Mark Gaydos, Sanofi
Bryant Godfrey, Foley Hoag
Matthew Hegreness, Covington & Burling LLP
Christine Humphrey-Antrim, C. Humphrey & Associates, P.A.
Danielle C Humphrey, Becton Dickinson (BD)
Tina Hu-Rodgers, Buchanan Ingersoll & Rooney PC
Michael L. Keech, IQVIA
Jae Kim, DLA Piper LLP (US)
Brittany Miller, Johnson & Johnson
Dominick Paul DiSabatino, Sheppard Mullin Richter & Hampton LLP
Heta Zaveri, Opus Regulatory, Inc.